In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan determined by the broth microdilution and disk diffusion methods

International Journal of Antimicrobial Agents

Volumn 32, Issue SUPPL. 3, 2008, Pages

  Liao, Chun Hsing ^a   Kung, Hsiang Chi ^b   Hsu, Gwo Jong ^c   Lu, Po Liang ^d   Liu, Yung Ching ^e   Chen, Chih Ming ^f   Lee, Chun Ming ^g   Sun, Wu ^h   Jang, Tsrang Neng ⁱ   Chiang, Ping Cherng ^j   Cheng, Yu Jen ^k   Lin, Hsiu Chen ^l   Shi, Zhi Yuan ^m   Wang, Lih Shinn ⁿ   Chuang, Yin Ching ^o   Tsao, Shih Ming ^p   Lu, Chin Te ^q   Liu, Jien Wei ^r   Huang, Cheng Hua ^s   Hsueh, Po Ren ^b  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^f TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^g MACKAY MEMORIAL HOSPITAL   (Taiwan)

^h Pao Chien Hospital   (Taiwan)

ⁱ SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^j CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^k CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^l TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^m TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

ⁿ BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^o CHI MEI MEDICAL CENTER   (Taiwan)

^p CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^q LOTUNG POH AI HOSPITAL   (Taiwan)

^r CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^s CATHAY GENERAL HOSPITAL   (Taiwan)

more..

Author keywords

Acinetobacter baumannii; Broth microdilution; Disk diffusion; Taiwan; Tigecycline

Indexed keywords

IMIPENEM; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ANALYTICAL ERROR; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; DISK DIFFUSION; DRUG SENSITIVITY; ENTEROBACTERIACEAE; FOOD AND DRUG ADMINISTRATION; HUMAN; IN VITRO STUDY; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TAIWAN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; TAIWAN;

EID: 55649098776     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(08)70027-X     Document Type: Article

References (18)

1. Gales A.C., Jones R.N., Forward K.R., Linares J., Sader H.S., and Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis 32 (2001) S104-S113
2. Gaynes R., Edwards J.R., and the National Nosocomial Infections Surveillance System. Overview of nosocomial infections caused by Gram-negative bacilli. Clin Infect Dis 41 (2005) 848-854
3. Gales A.C., and Jones R.N. Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1203 recent clinical bacterial isolates. Diagn Microbiol Infect Dis 36 (2000) 19-36
4. Livermore D.M. Tigecycline: what is it, and where should it be used?. J Antimicrob Chemother 56 (2005) 611-614
5. Navon-Venezia S., Leavitt A., and Carmeli Y. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother 59 (2007) 772-774
6. Hsueh P.R., Teng L.J., Chen C.Y., et al. Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan. Emerg Infect Dis 8 (2002) 827-832
7. Cheng N.C., Hsueh P.R., Liu C.Y., Shyr J.M., Huang W.K., Teng L.J., et al. In vitro activities of tigecycline, ertapenem, isepamicin, and other antimicrobial agents against clinically isolated organisms in Taiwan. Microb Drug Resist 11 (2005) 330-341
8. Karageorgopoulos D.E., Kelesidis T., Kelesidis I., and Falagas M.E. Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence. J Antimicrob Chemother 62 (2008) 45-55
9. Clinical and Laboratory Standards Institute. Methods for dilution antimi- crobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A7. 7th ed. (2006), Clinical and Laboratory Standards Institute, Wayne, PA
10. Hope R., Warner M., Mushtaq S., Ward M.E., Parsons T., and Livermore D.M. Effect of medium type, age and aeration on the MICs of tigecycline and classical tetracyclines. J Antimicrob Chemother 56 (2005) 1042-1046
11. th ed. (2006), Clinical and Laboratory Standards Institute, Wayne, PA
12. th informational supplement (2006), Clinical and Laboratory Standards Institute, Wayne, PA
13. Jones R.N., Ferraro M.J., Reller L.B., Schreckenberger P.C., Swenson J.M., and Sader H.S. Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. J Clin Microbiol 45 (2007) 227-230
14. nd ed. (2001), Clinical and Laboratory Standards Institute, Wayne, PA
15. Capone A., D'Arezzo S., Visca P., Petrosillo N., and on behalf of the Gruppo Romano Acinetobacter baumannii. In vitro activity of tigecycline against multidrug- resistant Acinetobacter baumannii. J Antimicrob Chemother 62 (2008) 422-423
16. Thamlikitkul V., Tiengrim S., and Tribuddharat C. Comment on: High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother 60 (2007) 177-178
17. Hope R., Parsons T., Mushtaq S., James D., and Livermore D.M. Determination of disc breakpoints and evaluation of Etests for tigecycline susceptibility testing by the BSAC method. J Antimicrob Chemother 60 (2007) 770-774
18. Curcio D., and Fernández F. Tigecycline disk diffusion breakpoints of Acinetobacter spp.: a clinical point of view. J Clin Microbiol 45 (2007) 2095-2096